ITIL-168 in Advanced Melanoma
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at La Jolla, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Gregory Daniels, MD, PhD
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSD
- Gregory Daniels, MD, PhD
Dr. Daniels coordinates our clinical program in melanoma. His own research involves understanding the link between autoimmunity and tumor immunity in developing more effective and less toxic vaccines and immune stimulatory approaches for patients with melanoma.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Instil Bio
- ID
- NCT05050006
- Phase
- Phase 2 Research Study
- Study Type
- Interventional
- Participants
- Expecting 130 study participants
- Last Updated